Name: Donataxel Injection
Company: BF Biosciences Limited
Therapeutic Segment: ONCOLOGY
Area: Breast Cancer
Donataxel contains Docetaxel 20 mg or 80 mg in glass vials. Docetaxel is approved for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer progression or relapsed. It is also used in regimens to treat ovarian cancer.
Prescribing Information